§ Sir Michael GryllsTo ask the Secretary of State for Health (1) if her Department will carry out a survey among United Kingdom pharmaceutical companies to establish how many potential new treatments for conditions covered by the proposed new limited list regulations are currently being investigated in their research and development laboratories;
(2) what positive measures her Department will take to persuade United Kingdom pharmaceutical companies to continue research projects in the 10 therapeutic categories covered by the proposed new limited list regulations; and whether such intentions would be incorporated into a revised pharmaceutical price regulation scheme.
§ Dr. MawhinneyThe Department does not collate information from the pharmaceutical industry on current research projects, and has no plans to do so. It is for the companies concerned to determine their research and development priorities within the framework provided by the pharmaceutical price regulation scheme.